“THE EFFECTIVENESS, IMMUNOGENICITY, AND SAFETY OF THE Escherichia coli BASED BIVALENT HUMAN PAPILLOMAVIRUS (TYPES 16 AND 18) VACCINE PREVENTING CERVICAL CANCER: A Systematic Review”, JIMKI, vol. 11, no. 3, pp. 21–37, Apr. 2025, doi: 10.53366/jimki.v11i3.795.